Program

The 11th Takeda Science Foundation Symposium on PharmaSciences

as of December 8, 2023
DAY 1

January 26
2024
09:30
Opening Remarks
Yasuteru UranoThe University of Tokyo, Japan
Session1-Part1

Chair: Yasuteru Urano, Gang Zheng

S1-1
09:40
CHEMICAL PROBES FOR IDENTIFICATION AND IMAGING OF HYDROLASES IMPORTANT FOR CANCER AND INFECTIOUS DISEASES
Matthew Bogyo
Stanford University School of Medicine, U.S.A.
S1-2
10:10
Addressing Optical Imaging Challenges through Molecular Afterglow Imaging and Artificial Urinary Biomarker Probes
Kanyi Pu
Nanyang Technological University, Singapore
Coffee Break 10:40-11:00 (20 min.)
Session1-Part2

Chair: Yasuteru Urano, Gang Zheng

S1-3
11:00
Translating fluorescent probes for imaging immune cell function in humans
Marc Vendrell
The University of Edinburgh, U.K.
S1-4
11:30
Near infrared photoimmunotherapy of cancer
Hisataka Kobayashi
National Cancer Institute, NIH and Kansai Medical University
S1-5
12:00
Porphysome Nanotechnology: Discovery, Translation and Beyond
Gang Zheng
University of Toronto and Princess Margaret Cancer Center, Canada
Lunch 12:30-13:15 (45 min.)
Poster Session 13:15-14:05 / Odd Number (50 min)
14:05-14:55 / Even Number (50 min)
Session1-Part3

Chair: Yasuteru Urano, Gang Zheng

S1-6
15:00
Therapeutic ln Vivo Synthetic Chemistry
Katsunori Tanaka
Tokyo Institute of Technology and RIKEN, Japan
S1-7
15:30
Chemical Medicine: Development of novel chemistry-based theranostics technologies for cancer
Yasuteru Urano
The University of Tokyo, Japan
Coffee Break 16:00-16:20 (20 min.)
Session2-Part1

Chair: Frederik L. Giesel, Koichi Fukase

S2-1
16:20
Boron neutron capture therapy and targeted alpha therapy: new radiotherapy strategy with LAT1 molecule and PET
Jun Hatazawa
Osaka University, Japan
S2-2
16:50
A Pretargeted Approach to Radiotheranostics
Jason S. Lewis
Memorial Sloan Kettering Cancer Center, U.S.A
S2-3
17:20
Role of extracellular vesicles during bystander cytotoxicity and bystander immunity of alpha-targeted radionuclide therapy
Jean-Pierre Pouget
Institute de Recherche en Cancérologie de Montpellier, INSERM, France
Welcome Reception 18:00-19:30 (90 min)
DAY 2

January 27
2024
Session2-Part2

Chair: Jason S. Lewis, Katsunori Tanaka

S2-4
09:00
Studies of targeted alpha therapy in Osaka University: development of At-211 labeled radiotherapeutics
Koichi Fukase
Osaka University, Japan
S2-5
09:30
Thorium and Actinium Conjugates for Targeted Alpha Therapy
Hartwig H. Hennekes
Bayer AG, Germany
S2-6
10:00
FAP-ligand for imaging and theranostics
Frederik L. Giesel
University Hospital Duesseldorf, Germany
Coffee Break 10:30-10:50 (20 min.)
Session3-Part1

Chair: Ichio Aoki, Peter Caravan

S3-1
10:50
Functional and theranostic contrast agents for MRI
Ichio Aoki
National Institutes for Quantum Science and Technology, Japan
S3-2
11:20
MRI of the Changing Brain
Alan P. Koretsky
National Institute of Neurological Disorders and Stroke, NIH, U.S.A
S3-3
11:50
Imaging brain activity with molecular MRI probes
Alan Jasanoff
Massachusetts Institute of Technology, U.S.A
Speaker's Photo Session 12:20-12:30 (10 min)
Lunch 12:30-13:20 (50 min.)
Poster Session -Free Discussion- 13:20-14:05 (45 min.)
Session3-Part2

Chair: Alan Jasanoff, Kazuya Kikuchi

S3-4
14:10
Applications of Molecular Imaging to the Development of Anti-Fibrotic Therapies
Peter Caravan
Massachusetts General Hospital and Harvard Medical School
S3-5
14:40
MRI of water cycling across cellular membranes, a tool to assess tumor metabolism
Silvio Aime
University of Torino, Italy
Coffee Break 15:10-15:30 (20 min.)
Session3-Part3

Chair: Alan P. Koretsky, Silvio Aime

S3-6
15:30
Advanced Magnetic Particle Imaging Complements Nuclear Medicine with zero radiation, zero prep, zero cytotoxicity, and zero half-life limitations
Steven Conolly
University of California Berkeley, U.S.A
S3-7
16:00
Development of 19F Magnetic Resonance Imaging Probe for in vivo Sensing Biomarkers
Kazuya Kikuchi
Osaka University, Japan
Award Ceremony & Closing Remarks 16:30-16:50 (20 min.)